- AU$2.00m
- AU$0.09m
- AU$1.48m
- 33
- 41
- 39
- 32
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.66 | ||
| Price to Tang. Book | 0.66 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 8.62 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -31.3% | ||
| Return on Equity | -26.54% | ||
| Operating Margin | -410.86% | ||
Financial Summary
| Year End 30th Jun | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 3.43 | 2.49 | 4.08 | 0.4 | 1.48 | n/a | n/a | -19.43% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Hexima Limited is an Australia-based company. The Company is exploring opportunities for transactions with third parties which could enable the potential value of the Company’s assets, including its intellectual property and other intangible assets, to be realized.
Directors
- Ross Dobinson CHM
- Adam Hall COO
- Robyn Heath SVP
- Helen Molloy CTR
- Phillip Rose OTH
- Leanne Ralph SEC
- Michael Aldridge DRC
- Scott Robertson DRC
- Nicole Van der Weerden DRC
- Justin Yap DRC
- Hugh Morgan NED
- Steven Skala NED
- Jake Nunn NID (45)
- Jonathan West NID
- Last Annual
- June 30th, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- July 17th, 1997
- Public Since
- December 1st, 2020
- No. of Shareholders
- 888
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
Australian Stock Exchange - SEATS- Shares in Issue
- 167,039,629
- Address
- La Trobe Institute for Molecular Science, MELBOURNE, 3086
- Web
- https://hexima.com.au/
- Phone
- +61 394791210
- Auditors
- KPMG
Upcoming Events for HXL
Similar to HXL
Actinogen Medical
Australian Stock Exchange - SEATS
Adalta
Australian Stock Exchange - SEATS
Algorae Pharmaceuticals
Australian Stock Exchange - SEATS
Alterity Therapeutics
Australian Stock Exchange - SEATS
Amplia Therapeutics
Australian Stock Exchange - SEATS
FAQ
What is the Hexima share price?
As of Today at 15:08 UTC, shares in Hexima are trading at AU$0.01. This share price information is delayed by 15 minutes.
How has the Hexima share price performed this year?
Shares in Hexima last closed at AU$0.01 and the price had moved by -52.38% over the past 365 days. In terms of relative price strength the Hexima share price has underperformed the ASX All Ordinaries Index by -56.63% over the past year.
What are the analyst and broker recommendations for Hexima?
The overall consensus recommendation for Hexima is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Hexima dividend yield?
Hexima does not currently pay a dividend.
Does Hexima pay a dividend?
Hexima does not currently pay a dividend.
When does Hexima next pay dividends?
Hexima does not currently pay a dividend.
How do I buy Hexima shares?
To buy shares in Hexima you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Hexima?
As of the previous close price of AU$0.01, shares in Hexima had a market capitalisation of AU$1.67m.
Where are Hexima shares listed?
Here are the trading details for Hexima:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: HXL
What kind of share is Hexima?
Based on an overall assessment of its quality, value and momentum Hexima is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Hexima share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Hexima share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Hexima. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -45.69%.
As of the last closing price of AU$0.01, shares in Hexima were trading -39.93% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Hexima PE Ratio?
The Hexima PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Hexima?
Hexima's management team is headed by:
- Ross Dobinson - CHM
- Adam Hall - COO
- Robyn Heath - SVP
- Helen Molloy - CTR
- Phillip Rose - OTH
- Leanne Ralph - SEC
- Michael Aldridge - DRC
- Scott Robertson - DRC
- Nicole Van der Weerden - DRC
- Justin Yap - DRC
- Hugh Morgan - NED
- Steven Skala - NED
- Jake Nunn - NID
- Jonathan West - NID